Cardiovascular Pharmacotherapy: Evidence-Based Solutions for Clinical Practice
Editat de Antonio Greco, Davide Capodannoen Limba Engleză Hardback – 21 aug 2026
Key Features:
- Summarizes current cardiovascular therapies, integrating pharmacological mechanisms with clinical evidence.
- Bridges science and practice, offering practical guidance for real-world clinical decision-making.
- Delivers comprehensive disease-oriented pharmacological approaches, guiding clinicians on how to use and combine drugs effectively for each cardiovascular condition.
| Toate formatele și edițiile | Preț | Express |
|---|---|---|
| Paperback (1) | 414.22 lei Precomandă | |
| CRC Press – 21 aug 2026 | 414.22 lei Precomandă | |
| Hardback (1) | 1353.36 lei Precomandă | |
| CRC Press – 21 aug 2026 | 1353.36 lei Precomandă |
Preț: 1353.36 lei
Preț vechi: 1644.40 lei
-18% Precomandă
Puncte Express: 2030
Preț estimativ în valută:
239.31€ • 274.49$ • 206.89£
239.31€ • 274.49$ • 206.89£
Carte nepublicată încă
Doresc să fiu notificat când acest titlu va fi disponibil:
Se trimite...
Specificații
ISBN-13: 9781041078425
ISBN-10: 1041078420
Pagini: 224
Ilustrații: 80
Dimensiuni: 178 x 254 mm
Ediția:1
Editura: CRC Press
Colecția CRC Press
ISBN-10: 1041078420
Pagini: 224
Ilustrații: 80
Dimensiuni: 178 x 254 mm
Ediția:1
Editura: CRC Press
Colecția CRC Press
Public țintă
Professional Practice & DevelopmentCuprins
PART I – Cardiovascular Drugs and Clinical Applications
1. Anti-Anginal Drugs
2. Anti-Arrhythmic Drugs
3. Antithrombotic Drugs
4. Beta-Blockers
5. Calcium-Channel Blockers
6. Diuretics
7. Glucagon-Like Peptide-1 Receptor Agonists
8. Lipid-Lowering Drugs
9. Renin-Angiotensin-Aldosterone System Inhibitors and Angiotensin Receptor-Neprilysin Inhibitor
10. Sodium-Glucose Cotransporter 2 Inhibitors
PART II – Integrated Disease Management: Practical Approaches
11. Coronary Artery Disease
12. Arrhythmias
13. Cardiomyopathies
14. Deep Vein Thrombosis and Pulmonary Embolism
15. Diabetes, Obesity and Metabolic Syndrome
16. Dyslipidemias
17. Heart Failure and Cardiogenic Shock
18. Hypertension
19. Inflammatory and Autoimmune Diseases
20. Pulmonary Hypertension
21. Stroke
1. Anti-Anginal Drugs
2. Anti-Arrhythmic Drugs
3. Antithrombotic Drugs
4. Beta-Blockers
5. Calcium-Channel Blockers
6. Diuretics
7. Glucagon-Like Peptide-1 Receptor Agonists
8. Lipid-Lowering Drugs
9. Renin-Angiotensin-Aldosterone System Inhibitors and Angiotensin Receptor-Neprilysin Inhibitor
10. Sodium-Glucose Cotransporter 2 Inhibitors
PART II – Integrated Disease Management: Practical Approaches
11. Coronary Artery Disease
12. Arrhythmias
13. Cardiomyopathies
14. Deep Vein Thrombosis and Pulmonary Embolism
15. Diabetes, Obesity and Metabolic Syndrome
16. Dyslipidemias
17. Heart Failure and Cardiogenic Shock
18. Hypertension
19. Inflammatory and Autoimmune Diseases
20. Pulmonary Hypertension
21. Stroke
Notă biografică
Antonio Greco
Dr. Antonio Greco, MD, PhD, is a Consultant Cardiologist at the Cardiovascular Department, Azienda Ospedaliero-Universitaria Policlinico "G. Rodolico—San Marco", University of Catania (Catania, Italy). He earned his MD (Medicine and Surgery) and PhD (Translational Biomedicine) degrees at the University of Catania (Catania, Italy). He also completed an advanced university course on Biomedical Statistics Applied to Research in the Human Field at the University of Palermo (Palermo, Italy) and a Second Level Master’s Degree (Advanced Biostatistics for Clinical Research) at the University of Padua (Padua, Italy).
Dr. Greco is the recipient of a highly competitive research grant funded by the Italian Ministry of University and Research. He has published more than 80 papers in peer-reviewed international journals and contributed to multiple chapters and textbooks in the field of cardiology. He has served as a scientific consultant for the European Commission and as a volunteer for the European Society of Cardiology. Dr. Greco has delivered over 30 invited lectures at national and international scientific meetings. His research activities mainly focus on cardiovascular pharmacotherapy, antithrombotic therapy, atherosclerotic cardiovascular disease, and cardiovascular disease prevention.
Davide Capodanno
Davide Capodanno, MD, PhD, is Full Professor of Cardiology at the University of Catania, Director of the Postgraduate School of Cardiovascular Diseases, and Director of the Cardiology Division at the Azienda Ospedaliero-Universitaria Policlinico “G. Rodolico–San Marco” in Catania, Italy. He earned his MD and PhD from the University of Catania and completed advanced research training at the University of Florida, Jacksonville.
Dr. Capodanno has authored more than 750 peer-reviewed publications and contributed to five textbooks and multiple chapters in interventional cardiology. He has delivered more than 400 invited lectures at international scientific meetings, including ESC, ACC, EuroPCR, TCT, and TCTAP. His research focuses on coronary revascularization, antithrombotic therapy, clinical trial methodology, and biostatistics.
Dr. Antonio Greco, MD, PhD, is a Consultant Cardiologist at the Cardiovascular Department, Azienda Ospedaliero-Universitaria Policlinico "G. Rodolico—San Marco", University of Catania (Catania, Italy). He earned his MD (Medicine and Surgery) and PhD (Translational Biomedicine) degrees at the University of Catania (Catania, Italy). He also completed an advanced university course on Biomedical Statistics Applied to Research in the Human Field at the University of Palermo (Palermo, Italy) and a Second Level Master’s Degree (Advanced Biostatistics for Clinical Research) at the University of Padua (Padua, Italy).
Dr. Greco is the recipient of a highly competitive research grant funded by the Italian Ministry of University and Research. He has published more than 80 papers in peer-reviewed international journals and contributed to multiple chapters and textbooks in the field of cardiology. He has served as a scientific consultant for the European Commission and as a volunteer for the European Society of Cardiology. Dr. Greco has delivered over 30 invited lectures at national and international scientific meetings. His research activities mainly focus on cardiovascular pharmacotherapy, antithrombotic therapy, atherosclerotic cardiovascular disease, and cardiovascular disease prevention.
Davide Capodanno
Davide Capodanno, MD, PhD, is Full Professor of Cardiology at the University of Catania, Director of the Postgraduate School of Cardiovascular Diseases, and Director of the Cardiology Division at the Azienda Ospedaliero-Universitaria Policlinico “G. Rodolico–San Marco” in Catania, Italy. He earned his MD and PhD from the University of Catania and completed advanced research training at the University of Florida, Jacksonville.
Dr. Capodanno has authored more than 750 peer-reviewed publications and contributed to five textbooks and multiple chapters in interventional cardiology. He has delivered more than 400 invited lectures at international scientific meetings, including ESC, ACC, EuroPCR, TCT, and TCTAP. His research focuses on coronary revascularization, antithrombotic therapy, clinical trial methodology, and biostatistics.
Descriere
This comprehensive guide to cardiovascular pharmacotherapy provides a clinically oriented overview of drugs in the field of cardiology. Written for healthcare professionals, it integrates latest evidence with clinical decision-making.